Wells Fargo enters its July 14 earnings print with a notable shift in options positioning — hedging demand has unwound sharply even as short sellers quietly rebuild positions, creating an unusual split between two measures that usually move together.
The most striking development is in options sentiment, and unusually, it points toward less caution rather than more. The put/call ratio has dropped to 1.29, well below its 20-day mean of 1.41 and nearly 1.8 standard deviations beneath that average — the least defensive options posture in recent weeks. That's a meaningful reversal from early June, when the PCR was running above 1.50, close to its 52-week high of 1.58. Investors appear to have shed the protective hedges they were carrying through most of June's first half.
Short interest tells a slightly different story, though it is far from alarming. At just 1.1% of the free float, the short base is small by any measure. It has edged up 4.3% over the past week and 18.6% over the past month, but from such a low starting point those moves amount to roughly 1.5 million additional shares. Borrow costs are essentially negligible at 0.28% and falling — down 9% on the week and 29% over the past month. Availability is practically unlimited, with the lending pool showing no sign of strain. The short-interest build looks opportunistic rather than structural.
The Street is cautiously constructive heading into the print. Morgan Stanley's Betsy Graseck raised her target to $102 last week while keeping an Equal-Weight rating — an upgrade in conviction on price but not on relative positioning. Truist lifted its target to $94 with a Buy. The consensus mean target of $96.52 implies roughly 17% upside to the $82.64 close, which is wide enough to reflect genuine disagreement about the pace of the recovery rather than a settled bullish view. The bull case centers on book value per share climbing to $53.24 and core ROE reaching 13.3%. Bears point to the CET1 ratio slipping to 10.6% and noninterest income falling to $8.96 billion from $9.49 billion the prior quarter. On valuation, the P/E multiple has expanded nearly a full point over the past 30 days to 11.3x, and price-to-book has risen 0.13 turns to 1.45x — modest re-rating rather than exuberance. The ORTEX short score is benign at 29.5, while the dividend score ranks in the 96th percentile and days-to-cover in the 78th.
The earnings history adds context worth noting. The April 14 Q1 print produced a one-day drop of 7.3% and the stock was still down 5.9% five days later — a punishing reaction. The subsequent April 28 event generated a 1.2% gain but gave most of it back over the following week. That asymmetry — sharp falls, modest recoveries — has made options traders historically skittish into results, which makes the current retreat in hedging demand the more interesting data point. Peers are broadly weak on the week: BAC fell 1.6% and JPM dropped 2.0%, while regional names MTB and RF managed gains of 2.9% and 3.1% respectively, suggesting money rotating into regionals even as the money-center banks slid.
What to watch going into July 14: whether the net interest margin trajectory and CET1 stabilisation can square the circle between an options market that has just dropped its guard and a short base that has been quietly growing for a month.
See the live data behind this article on ORTEX.
Open WFC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
